PyInvesting

Market research

0512.HK China Grand Pharmaceutical and Healthcare Holdings Limited

HK HKD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
17B
P/E ratio
14.01
Analyst target
9.5267
Dividend yield
3.4%
Beta
0.67

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

China Grand Pharmaceutical and Healthcare Holdings Limited is currently in a long term uptrend where the price is trading 2.2% above its 200 day moving average.

From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.

China Grand Pharmaceutical and Healthcare Holdings Limited's total revenue rose by 3.1% to $3B since the same quarter in the previous year.

Its net income has increased by 77.8% to $1B since the same quarter in the previous year.

Finally, its free cash flow grew by 294.2% to $219M since the same quarter in the previous year.

Based on the above factors, China Grand Pharmaceutical and Healthcare Holdings Limited gets an overall score of 5/5.